Remedy Robotics raised a $62M Series B to fund a pivotal clinical trial of its N1 robot, which performs catheter-based stroke and cardiovascular procedures and can be operated remotely. DCVC led the round.
- Company
- Remedy Robotics remedyrobotics.com
- Round
- Series B
- Amount
- $62M
- Source
- prnewswire.com